| Reinforcement Learning for Personalized Drug Discovery and Design for Complex Diseases: A Systems Pharmacology Perspective | Jan 21, 2022 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Mining for Potent Inhibitors through Artificial Intelligence and Physics: A Unified Methodology for Ligand Based and Structure Based Drug Design | Oct 5, 2021 | Deep Reinforcement LearningDrug Design | —Unverified | 0 | 0 |
| Representation Learning on Graphs: Methods and Applications | Sep 17, 2017 | BIG-bench Machine LearningDimensionality Reduction | —Unverified | 0 | 0 |
| Research and development of MolAICal for drug design via deep learning and classical programming | Jun 17, 2020 | Deep LearningDrug Design | —Unverified | 0 | 0 |
| Rethinking Specificity in SBDD: Leveraging Delta Score and Energy-Guided Diffusion | Mar 4, 2024 | Contrastive LearningDrug Design | —Unverified | 0 | 0 |
| Retro Drug Design: From Target Properties to Molecular Structures | May 11, 2021 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| RetroGNN: Approximating Retrosynthesis by Graph Neural Networks for De Novo Drug Design | Nov 25, 2020 | Drug DesignRetrosynthesis | —Unverified | 0 | 0 |
| Retro-prob: Retrosynthetic Planning Based on a Probabilistic Model | May 25, 2024 | Drug DesignRetrosynthesis | —Unverified | 0 | 0 |
| Rigidity strengthening is a vital mechanism for protein-ligand binding | Mar 31, 2017 | Drug DesignProtein Design | —Unverified | 0 | 0 |
| SAFE setup for generative molecular design | Oct 26, 2024 | Data AugmentationDrug Design | —Unverified | 0 | 0 |
| Scaffold-constrained molecular generation | Sep 15, 2020 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| ScatterSample: Diversified Label Sampling for Data Efficient Graph Neural Network Learning | Jun 9, 2022 | Active LearningDrug Design | —Unverified | 0 | 0 |
| Evaluating Molecule Synthesizability via Retrosynthetic Planning and Reaction Prediction | Nov 13, 2024 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Self-Organizing Maps of Unbiased Ligand-Target Binding Pathways and Kinetics | Sep 19, 2024 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Semi-Supervised GCN for learning Molecular Structure-Activity Relationships | Jan 25, 2022 | Drug DesignGraph Neural Network | —Unverified | 0 | 0 |
| Shape Complementarity Analysis for Objects of Arbitrary Shape | Dec 1, 2017 | Drug Designglobal-optimization | —Unverified | 0 | 0 |
| Shape-conditioned 3D Molecule Generation via Equivariant Diffusion Models | Aug 23, 2023 | 3D Molecule GenerationDrug Design | —Unverified | 0 | 0 |
| ShEPhERD: Diffusing shape, electrostatics, and pharmacophores for bioisosteric drug design | Oct 22, 2024 | Drug Design | —Unverified | 0 | 0 |
| Spherical Distance Metrics Applied to Protein Structure Classification | Dec 18, 2015 | ClassificationClustering | —Unverified | 0 | 0 |
| Stabilizing Policy Gradients for Stochastic Differential Equations via Consistency with Perturbation Process | Mar 7, 2024 | Drug DesignPolicy Gradient Methods | —Unverified | 0 | 0 |
| StriderNET: A Graph Reinforcement Learning Approach to Optimize Atomic Structures on Rough Energy Landscapes | Jan 29, 2023 | Drug Design | —Unverified | 0 | 0 |
| STRIDE: Structure-guided Generation for Inverse Design of Molecules | Nov 6, 2023 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Structural insights into characterizing binding sites in EGFR kinase mutants | Dec 27, 2018 | Drug Design | —Unverified | 0 | 0 |
| Structure-aware generation of drug-like molecules | Nov 7, 2021 | Drug Design | —Unverified | 0 | 0 |
| Structure-Based Drug Design via 3D Molecular Generative Pre-training and Sampling | Feb 22, 2024 | Drug DesignMolecular Docking | —Unverified | 0 | 0 |
| Structure-based drug design with geometric deep learning | Oct 19, 2022 | Deep LearningDrug Design | —Unverified | 0 | 0 |
| Surveying the side-chain network approach to protein structure and dynamics: The SARS-CoV-2 spike protein as an illustrative case | Sep 9, 2020 | Drug Design | —Unverified | 0 | 0 |
| SynerGPT: In-Context Learning for Personalized Drug Synergy Prediction and Drug Design | Jun 19, 2023 | Drug DesignIn-Context Learning | —Unverified | 0 | 0 |
| Synthesis-driven design of 3D molecules for structure-based drug discovery using geometric transformers | Dec 31, 2022 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| SynthFormer: Equivariant Pharmacophore-based Generation of Synthesizable Molecules for Ligand-Based Drug Design | Oct 3, 2024 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Systems-Structure-Based Drug Design | Oct 14, 2024 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Targets of drugs are generally, and targets of drugs having side effects are specifically good spreaders of human interactome perturbations | May 13, 2015 | Drug Design | —Unverified | 0 | 0 |
| CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models | Apr 2, 2020 | AttributeDrug Design | —Unverified | 0 | 0 |
| Template-Guided 3D Molecular Pose Generation via Flow Matching and Differentiable Optimization | May 22, 2025 | Drug DesignPose Prediction | —Unverified | 0 | 0 |
| GlycoNMR: Dataset and benchmarks for NMR chemical shift prediction of carbohydrates with graph neural networks | Nov 28, 2023 | Drug Designmolecular representation | —Unverified | 0 | 0 |
| tFold-TR: Combining Deep Learning Enhanced Hybrid Potential Energy for Template-Based Modeling Structure Refinement | May 10, 2021 | Drug DesignProtein Structure Prediction | —Unverified | 0 | 0 |
| The known unknowns of the Hsp90 chaperone | Aug 31, 2023 | Drug DesignKnown Unknowns | —Unverified | 0 | 0 |
| The recent advances in the mathematical modelling of human pluripotent stem cells | Sep 23, 2019 | Drug Design | —Unverified | 0 | 0 |
| The Structural Biology and Critical Evaluation of Bacterial Proteases as Targets in New Drug Design | Jun 3, 2014 | Drug DesignSpecificity | —Unverified | 0 | 0 |
| Token-Mol 1.0: Tokenized drug design with large language model | Jul 10, 2024 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Towards Efficient Molecular Property Optimization with Graph Energy Based Models | Feb 17, 2025 | Drug Design | —Unverified | 0 | 0 |
| Towards Interpretable Sparse Graph Representation Learning with Laplacian Pooling | May 28, 2019 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Hybrid quantum-classical machine learning for generative chemistry and drug design | Aug 26, 2021 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| TransDiffSBDD: Causality-Aware Multi-Modal Structure-Based Drug Design | Mar 26, 2025 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Transfer Learning for Bayesian Optimization: A Survey | Feb 12, 2023 | Bayesian OptimizationDrug Design | —Unverified | 0 | 0 |
| Transformative Machine Learning | Nov 8, 2018 | BIG-bench Machine LearningDrug Design | —Unverified | 0 | 0 |
| Two for the Price of One: Integrating Large Language Models to Learn Biophysical Interactions | Mar 26, 2025 | Computational EfficiencyDrug Design | —Unverified | 0 | 0 |
| Understanding of Genetic Code Degeneracy and New Way of Classifying of Protein Family: A Mathematical Approach | Nov 30, 2015 | Drug Design | —Unverified | 0 | 0 |
| Understanding Protein Dynamics with L1-Regularized Reversible Hidden Markov Models | May 6, 2014 | Distributed ComputingDrug Design | —Unverified | 0 | 0 |
| Unified Guidance for Geometry-Conditioned Molecular Generation | Jan 5, 2025 | Drug Design | —Unverified | 0 | 0 |